Clinical Significance of MMP7 Levels in Colorectal Cancer Patients Receiving FOLFOX4 Chemotherapy Treatment

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.21601
   PubMed Web of Science ®Google Scholar
• Suenaga M, Fujimoto Y, Matsusaka S, et al. Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01). Onco Targets Ther. 2015;8:1111–1118. doi:10.2147/OTT.S83952
   PubMed Web of Science ®Google Scholar
• Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther. 2020;206:107447. doi:10.1016/j.pharmthera.2019.107447
   PubMed Web of Science ®Google Scholar
• Sali L, Falchini M, Taddei A, Mascalchi M. Role of preoperative CT colonography in patients with colorectal cancer. World J Gastroenterol. 2014;20(14):3795–3803. doi:10.3748/wjg.v20.i14.3795
   PubMed Web of Science ®Google Scholar
• Campos-da-Paz M, Dorea JG, Galdino AS, Lacava ZGM, de Fatima Menezes Almeida Santos M. Carcinoembryonic Antigen (CEA) and hepatic metastasis in colorectal cancer: update on biomarker for clinical and biotechnological approaches. Recent Pat Biotechnol. 2018;12(4):269–279. doi:10.2174/1872208312666180731104244
   PubMedGoogle Scholar
• Hidaka E, Maeda C, Nakahara K, et al. High serum CA19-9 concentration predicts poor prognosis in elderly patients with stage IV colorectal cancer. Gastrointest Tumors. 2019;5(3–4):117–124. doi:10.1159/000493793
   PubMed Web of Science ®Google Scholar
• Rong W, Zhang Y, Yang L, et al. Post-surgical resection prognostic value of combined OPN, MMP7, and PSG9 plasma biomarkers in hepatocellular carcinoma. Front Med. 2019;13(2):250–258. doi:10.1007/s11684-018-0632-1
   PubMed Web of Science ®Google Scholar
• Fu CK, Chien YC, Chuang HY, et al. The association of MMP7 promoter polymorphisms with gastric cancer. Anticancer Res. 2020;40(2):695–702. doi:10.21873/anticanres.13999
   PubMed Web of Science ®Google Scholar
• Yu B, Liu X, Chang H. MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7. Minerva Med. 2017;108(1):13–19. doi:10.23736/S0026-4806.16.04651-6
   PubMed Web of Science ®Google Scholar
• Gao Y, Nan X, Shi X, et al. SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-kappaB pathway activation. BMC Cancer. 2019;19(1):685. doi:10.1186/s12885-019-5904-x
   PubMedGoogle Scholar
• Bufu T, Di X, Yilin Z, Gege L, Xi C, Ling W. Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway. Anticancer Drugs. 2018;29(6):530–538. doi:10.1097/CAD.0000000000000621
   PubMed Web of Science ®Google Scholar
• Horndler C, Gallego R, Garcia-Albeniz X, et al. Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor I (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximab or panitumumab: a GEMCAD study. Cancer Biol Ther. 2011;11(2):177–183. doi:10.4161/cbt.11.2.13839
   PubMed Web of Science ®Google Scholar
• Almendro V, Ametller E, Garcia-Recio S, et al. The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin. PLoS One. 2009;4(3):e4728. doi:10.1371/journal.pone.0004728
   PubMed Web of Science ®Google Scholar
• Kumar P, Siripini S, Sreedhar AS. The matrix metalloproteinase 7 (MMP7) links Hsp90 chaperone with acquired drug resistance and tumor metastasis. Cancer Rep. 2020;5(12):e1261.
   Google Scholar
• Ren J, Smid M, Iaria J, et al. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression. Breast Cancer Res. 2019;21(1):109. doi:10.1186/s13058-019-1194-0
   PubMed Web of Science ®Google Scholar
• Zhang X, Hu F, Li G, et al. Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling. Cell Death Dis. 2018;9(2):25. doi:10.1038/s41419-017-0176-3
   PubMedGoogle Scholar
• Taniguchi S, Elhance A, Van Duzer A, Kumar S, Leitenberger JJ, Oshimori N. Tumor-initiating cells establish an IL-33-TGF-beta niche signaling loop to promote cancer progression. Science. 2020;369(6501). doi:10.1126/science.aay1813
   PubMed Web of Science ®Google Scholar
• Thomas DS, Fourkala EO, Apostolidou S, et al. Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. Br J Cancer. 2015;113(2):268–274. doi:10.1038/bjc.2015.202
   PubMed Web of Science ®Google Scholar
• Nikiteas NI, Tzanakis N, Gazouli M, et al. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol. 2005;11(11):1639–1643. doi:10.3748/wjg.v11.i11.1639
   PubMed Web of Science ®Google Scholar
• Beeghly-Fadiel A, Shu XO, Long J, et al. Genetic polymorphisms in the MMP-7 gene and breast cancer survival. Int J Cancer. 2009;124(1):208–214. doi:10.1002/ijc.23859
   PubMed Web of Science ®Google Scholar
• Gao Q, Wang XY, Qiu SJ, et al. Tumor stroma reaction-related gene signature predicts clinical outcome in human hepatocellular carcinoma. Cancer Sci. 2011;102(8):1522–1531. doi:10.1111/j.1349-7006.2011.01981.x
   PubMed Web of Science ®Google Scholar
• Manuel V-A, Nuria T, Moisés B-C, Mar H-C, Luis -A-A. Serum levels of macrophage inhibitory cytokine-1 (MIC1) and matrix metallopeptidase-7 (MMP7) as diagnostic and prognostic markers in gastric cancer (GC) patients (pts). J Clin Oncol. 2012. doi:10.1200/jco.2012.30.15_suppl.e14595
   Web of Science ®Google Scholar
• Chen L, Ke X. MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis. Medicine. 2021;100(9):e24953. doi:10.1097/MD.0000000000024953
   PubMed Web of Science ®Google Scholar
• Klupp F, Neumann L, Kahlert C, et al. Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients. BMC Cancer. 2016;16(1):494. doi:10.1186/s12885-016-2515-7
   PubMed Web of Science ®Google Scholar
• Li H, Xu X, Liu Y, et al. MMP7 induces T-DM1 resistance and leads to the poor prognosis of gastric adenocarcinoma via a DKK1-dependent manner. Anticancer Agents Med Chem. 2018;18(14):2010–2016. doi:10.2174/1871520619666181203111329
   PubMed Web of Science ®Google Scholar